Vitamin D and Autoimmune Diseases

[1]  R. Ionescu,et al.  Dysregulation of anergy‐related factors involved in regulatory T cells defects in Systemic Lupus Erythematosus patients: Rapamycin and Vitamin D efficacy in restoring regulatory T cells , 2016, International journal of rheumatic diseases.

[2]  H. Amital,et al.  Association between seasonal factors and multiple sclerosis , 2016, European Journal of Epidemiology.

[3]  Y. Shoenfeld,et al.  Vitamin D and autoimmunity , 2016, Scandinavian journal of rheumatology.

[4]  H. Kalim,et al.  Vitamin D prevents endothelial damage induced by increased neutrophil extracellular traps formation in patients with systemic lupus erythematosus. , 2016, Acta medica Indonesiana.

[5]  Y. Shoenfeld,et al.  Eppur Si Muove: vitamin D is essential in preventing and modulating SLE , 2016, Lupus.

[6]  E. Bonfá,et al.  Vitamin D Supplementation in Adolescents and Young Adults With Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double‐Blind, Placebo‐Controlled Trial , 2016, Arthritis care & research.

[7]  R. Ho,et al.  25-Hydroxyvitamin D3 Deficiency Independently Predicts Cognitive Impairment in Patients with Systemic Lupus Erythematosus , 2015, PloS one.

[8]  F. Cantatore,et al.  Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis , 2015, PloS one.

[9]  N. Chaturvedi,et al.  Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study , 2015, Cardiovascular Diabetology.

[10]  F. Dall’ara,et al.  A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus , 2015, Lupus.

[11]  A. Hoi,et al.  Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort , 2015, Lupus Science & Medicine.

[12]  H. Marzouk,et al.  Vitamin D status in Egyptian patients with juvenile-onset systemic lupus erythematosus , 2015, Rheumatology International.

[13]  M. Vakili,et al.  Effect of vitamin d3 supplement in glycemic control of pediatrics with type 1 diabetes mellitus and vitamin d deficiency. , 2015, Journal of clinical and diagnostic research : JCDR.

[14]  E. Morand,et al.  Vitamin D and systemic lupus erythematosus: continued evolution , 2015, International journal of rheumatic diseases.

[15]  Y. Shoenfeld,et al.  Vitamin D and thyroid autoimmune diseases: the known and the obscure , 2015, Immunologic research.

[16]  J. Sabio,et al.  Association between low 25-hydroxyvitamin D, insulin resistance and arterial stiffness in nondiabetic women with systemic lupus erythematosus , 2015, Lupus.

[17]  Татьяна Эдуардовна Боровик,et al.  НЕДОСТАТОЧНОСТЬ ВИТАМИНА D У ДЕТЕЙ РАННЕГО ВОЗРАСТА В РОССИИ: РЕЗУЛЬТАТЫ МНОГОЦЕНТРОВОГО КОГОРТНОГО ИССЛЕДОВАНИЯ РОДНИЧОК (2013–2014 ГГ.) , 2014 .

[18]  M. Bastos,et al.  Association of hypovitaminosis D with Systemic Lupus Erythematosus and inflammation. , 2014, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[19]  G. Reeves,et al.  Vitamin D Levels Are Associated with Expression of SLE, but Not Flare Frequency , 2014, International journal of rheumatology.

[20]  I. Bruce,et al.  25‐Hydroxyvitamin D and Cardiovascular Disease in Patients With Systemic Lupus Erythematosus: Data From a Large International Inception Cohort , 2014, Arthritis care & research.

[21]  M. Salehi,et al.  Correlation between serum 25(OH)D values and lupus disease activity: an original article and a systematic review with meta-analysis focusing on serum VitD confounders , 2014, Lupus.

[22]  J. Piette,et al.  Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up , 2014, Lupus Science & Medicine.

[23]  M. Cerinic,et al.  Vitamin D levels in children, adolescents, and young adults with juvenile-onset systemic lupus erythematosus: a cross-sectional study , 2014, Lupus.

[24]  M. Cantorna,et al.  Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease , 2014, Experimental biology and medicine.

[25]  T. McGhie,et al.  Vitamin D levels in Jamaican patients with systemic lupus erythematosus , 2014, Lupus.

[26]  F. Barkhof,et al.  Vitamin D as an early predictor of multiple sclerosis activity and progression. , 2014, JAMA neurology.

[27]  O. Monticielo,et al.  Vitamin D and systemic lupus erythematosus: state of the art , 2014, Clinical Rheumatology.

[28]  Aditya K Panda,et al.  Vitamin D levels in Indian systemic lupus erythematosus patients: association with disease activity index and interferon alpha , 2014, Arthritis Research & Therapy.

[29]  H. Kalim,et al.  Effects of 1,25(OH)2D3 in immune response regulation of systemic lupus erithematosus (SLE) patient with hypovitamin D. , 2014, International journal of clinical and experimental medicine.

[30]  B. Sathian,et al.  Time Trends and Inequalities of Under-Five Mortality in Nepal: A Secondary Data Analysis of Four Demographic and Health Surveys between 1996 and 2011 , 2013, PloS one.

[31]  Y. Shoenfeld,et al.  Vitamin D in Systemic and Organ-Specific Autoimmune Diseases , 2013, Clinical Reviews in Allergy & Immunology.

[32]  A. El-Shal,et al.  Role of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D level in Egyptian female patients with systemic lupus erythematosus , 2013, Molecular Biology Reports.

[33]  L. Nagy,et al.  The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology. , 2013, The Journal of allergy and clinical immunology.

[34]  L. Magder,et al.  Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. , 2013, Arthritis and rheumatism.

[35]  M. Holick,et al.  Vitamin D for health: a global perspective. , 2013, Mayo Clinic proceedings.

[36]  C. Mok.  Vitamin D and systemic lupus erythematosus: an update , 2013, Expert review of clinical immunology.

[37]  P. Narongroeknawin,et al.  Current Daily Glucocorticoid Use and Serum Creatinine Levels Are Associated With Lower 25(OH) Vitamin D Levels in Thai Patients With Systemic Lupus Erythematosus , 2013, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[38]  D. Cottrell,et al.  Primary progressive multiple sclerosis: progress and challenges , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[39]  A. Raymond,et al.  The Clinical Significance of Vitamin D in Systemic Lupus Erythematosus: A Systematic Review , 2013, PloS one.

[40]  N. Bizzaro,et al.  Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. , 2012, Autoimmunity reviews.

[41]  S. Arias-Santiago,et al.  Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. , 2012, Journal of the American Academy of Dermatology.

[42]  C. McCulloch,et al.  Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis , 2012, Annals of neurology.

[43]  P. Jenum,et al.  Maternal Serum Levels of 25-Hydroxy-Vitamin D During Pregnancy and Risk of Type 1 Diabetes in the Offspring , 2011, Diabetes.

[44]  G. Poli,et al.  Macrophage Polarization in Health and Disease , 2011, TheScientificWorldJournal.

[45]  J. Damoiseaux,et al.  Effects of vitamin D on the peripheral adaptive immune system: a review. , 2011, Autoimmunity reviews.

[46]  C. Mathieu,et al.  Vitamin D in autoimmune, infectious and allergic diseases: a vital player? , 2011, Best practice & research. Clinical endocrinology & metabolism.

[47]  Sneha S. Joshi,et al.  1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A , 2011, Molecular and Cellular Biology.

[48]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[49]  J. Manson,et al.  Does vitamin D affect risk of developing autoimmune disease?: a systematic review. , 2011, Seminars in arthritis and rheumatism.

[50]  A. Ananthakrishnan,et al.  Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. , 2011, JPEN. Journal of parenteral and enteral nutrition.

[51]  Y. Shoenfeld,et al.  Vitamin D and autoimmune thyroid diseases , 2011, Cellular and Molecular Immunology.

[52]  A. Reimold,et al.  Prevalence of Vitamin D Insufficiency/Deficiency in Rheumatoid Arthritis and Associations with Disease Severity and Activity , 2011, The Journal of Rheumatology.

[53]  C. Mathieu,et al.  The Vitamin D Analog, TX527, Promotes a Human CD4+CD25highCD127low Regulatory T Cell Profile and Induces a Migratory Signature Specific for Homing to Sites of Inflammation , 2011, The Journal of Immunology.

[54]  JoAnn E. Manson,et al.  The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.

[55]  Thomas J. Wang,et al.  Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. , 2010, Autoimmunity reviews.

[56]  G. Ebers,et al.  Genetic and environmental factors and the distribution of multiple sclerosis in Europe , 2010, European journal of neurology.

[57]  C. Mathieu,et al.  Vitamin D: modulator of the immune system. , 2010, Current opinion in pharmacology.

[58]  C. Mathieu,et al.  Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[59]  R. Jorde,et al.  No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. , 2010, Cytokine.

[60]  C. Geisler,et al.  Vitamin D controls T cell antigen receptor signaling and activation of human T cells , 2010, Nature Immunology.

[61]  E. Karlson,et al.  Association between Residences in U.S. Northern Latitudes and Rheumatoid Arthritis: A Spatial Analysis of the Nurses’ Health Study , 2010, Environmental health perspectives.

[62]  Y. Shoenfeld,et al.  The role of vitamin D in regulating immune responses. , 2010, The Israel Medical Association journal : IMAJ.

[63]  T. Pieber,et al.  Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? , 2010, The Israel Medical Association journal : IMAJ.

[64]  Patrick J. F. Groenen,et al.  Genome-wide association studies and the genetics of entrepreneurship , 2010, European Journal of Epidemiology.

[65]  M. Mura,et al.  1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP31 , 2009, The Journal of Immunology.

[66]  Y. Allanore,et al.  Vitamin D Deficiency and Insufficiency in 2 Independent Cohorts of Patients with Systemic Sclerosis , 2009, The Journal of Rheumatology.

[67]  M. T. Parra,et al.  A High Incidence of Meiotic Silencing of Unsynapsed Chromatin Is Not Associated with Substantial Pachytene Loss in Heterozygous Male Mice Carrying Multiple Simple Robertsonian Translocations , 2009, PLoS genetics.

[68]  T. Trikalinos,et al.  Vitamin D and calcium: a systematic review of health outcomes. , 2009, Evidence report/technology assessment.

[69]  BD Beretich,et al.  Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis , 2009, Multiple sclerosis.

[70]  J. Correale,et al.  Immunomodulatory effects of Vitamin D in multiple sclerosis. , 2009, Brain : a journal of neurology.

[71]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[72]  J. Knight,et al.  Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D , 2009, PLoS genetics.

[73]  S. Mohr,et al.  The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide , 2008, Diabetologia.

[74]  E. Rimm,et al.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. , 2008, Archives of internal medicine.

[75]  Eun-So Lee,et al.  Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. , 2008, Rheumatology.

[76]  A. Akobeng,et al.  Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis , 2008, Archives of Disease in Childhood.

[77]  G. Ebers.  Environmental factors and multiple sclerosis , 2008, The Lancet Neurology.

[78]  A. Ascherio,et al.  Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention , 2008, Seminars in neurology.

[79]  M. Cutolo,et al.  Vitamin D in rheumatoid arthritis. , 2007, Autoimmunity reviews.

[80]  E. Karlson,et al.  Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women , 2007, Annals of the rheumatic diseases.

[81]  D. Mendonça,et al.  The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population , 2007, Journal of the Neurological Sciences.

[82]  A. Silman,et al.  Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. , 2007, Arthritis and rheumatism.

[83]  Y. Shoenfeld,et al.  Vitamin D and autoimmunity: new aetiological and therapeutic considerations , 2007, Annals of the rheumatic diseases.

[84]  M. Ward,et al.  Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. , 2007, Arthritis and rheumatism.

[85]  P. Krause,et al.  Determinants of vitamin D levels in nursing home residents. , 2007, Journal of the American Medical Directors Association.

[86]  B. Stockinger.  Th17 cells: An orphan with influence , 2007, Immunology and cell biology.

[87]  M. Cutolo,et al.  Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. , 2006, Clinical and experimental rheumatology.

[88]  M. Rehli,et al.  Monocyte-derived cells express CYP27A1 and convert vitamin D3 into its active metabolite. , 2006, Biochemical and biophysical research communications.

[89]  S. Hanauer,et al.  Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities , 2006, Inflammatory bowel diseases.

[90]  C. Mathieu,et al.  Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[91]  David Feldman,et al.  Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. , 2005, Cancer research.

[92]  S. Hanauer,et al.  Mechanisms of Disease: vitamin D and inflammatory bowel disease , 2005, Nature Clinical Practice Gastroenterology &Hepatology.

[93]  C. Mathieu,et al.  1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. , 2005, Endocrinology.

[94]  B. Hollis.  Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. , 2005, The Journal of nutrition.

[95]  M. Holick.  Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. , 2004, The American journal of clinical nutrition.

[96]  M. Cantorna,et al.  Mounting Evidence for Vitamin D as an Environmental Factor Affecting Autoimmune Disease Prevalence , 2004, Experimental biology and medicine.

[97]  John H. White,et al.  Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression , 2004, The Journal of Immunology.

[98]  W. Willett,et al.  Vitamin D intake and incidence of multiple sclerosis , 2004, Neurology.

[99]  J. Welsh,et al.  A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. , 2003, Molecular endocrinology.

[100]  M. Cantorna,et al.  The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells , 2003, Journal of cellular biochemistry.

[101]  Aristides G. Eliopoulos,et al.  Differential Regulation of Vitamin D Receptor and Its Ligand in Human Monocyte-Derived Dendritic Cells1 , 2003, The Journal of Immunology.

[102]  E. Wolf,et al.  Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[103]  W. Leslie,et al.  AGA technical review on osteoporosis in gastrointestinal diseases. , 2003, Gastroenterology.

[104]  M. Uskoković,et al.  Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases , 2003 .

[105]  F. Cosman,et al.  Cytokine profile in patients with multiple sclerosis following vitamin D supplementation , 2003, Journal of Neuroimmunology.

[106]  A. Ponsonby,et al.  Ultraviolet radiation and autoimmune disease: insights from epidemiological research. , 2002, Toxicology.

[107]  M. Willcox,et al.  1α,25‐Dihydroxyvitamin D3 inhibits pro‐inflammatory cytokine and chemokine expression in human corneal epithelial cells colonized with Pseudomonas aeruginosa , 2002, Immunology and cell biology.

[108]  M. Uskoković,et al.  A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice , 2002 .

[109]  L. Freedman,et al.  1,25-Dihydroxyvitamin D3 Inhibits IFN-γ and IL-4 Levels During In Vitro Polarization of Primary Murine CD4+ T Cells1 , 2002, The Journal of Immunology.

[110]  M. Manns,et al.  Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis , 2002, Hepatology.

[111]  Virginia Pascual,et al.  Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus , 2001, Science.

[112]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[113]  Huub F. J. Savelkoul,et al.  1α,25-Dihydroxyvitamin D3 Has a Direct Effect on Naive CD4+ T Cells to Enhance the Development of Th2 Cells1 , 2001, The Journal of Immunology.

[114]  H. Koeffler,et al.  Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. , 2001, Clinical immunology.

[115]  M. Cantorna,et al.  1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. , 2000, The Journal of nutrition.

[116]  S. Romagnani,et al.  T-cell subsets (Th1 versus Th2). , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[117]  R. Kumar,et al.  Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. , 2000, Biochemical and biophysical research communications.

[118]  L. Adorini,et al.  1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.

[119]  M. Cantorna,et al.  Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[120]  C. Gössl,et al.  Seasonal fluctuations of gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis , 2000, Annals of neurology.

[121]  N. Pejnović,et al.  Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. , 1999, Clinical and experimental rheumatology.

[122]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[123]  H. DeLuca,et al.  1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. , 1998, Journal of immunology.

[124]  E. Shevach,et al.  CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. , 1998, Journal of immunology.

[125]  J. Gallagher,et al.  Dietary calcium and vitamin D intake in elderly women: effect on serum parathyroid hormone and vitamin D metabolites. , 1998, The American journal of clinical nutrition.

[126]  M. Hochberg,et al.  Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1996 .

[127]  J. Lemire.  Immunomodulatory role of 1,25‐dihydroxyvitamin D3 , 1992, Journal of cellular biochemistry.

[128]  D. Podolsky,et al.  Inflammatory bowel disease (1) , 1991, The New England journal of medicine.

[129]  N. Walworth,et al.  Effect of 1α,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions , 1986 .

[130]  S. Krane,et al.  Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. , 1983, The Journal of clinical endocrinology and metabolism.

[131]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[132]  G. Weinstein,et al.  Treatment of psoriasis. , 1976, The New England journal of medicine.

[133]  Grace K. Kim,et al.  Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria. , 2013, The Journal of clinical and aesthetic dermatology.

[134]  H. Kalim,et al.  Association between the low levels of vitamin D and Treg function in systemic lupus erythematosus patients. , 2013, Acta medica Indonesiana.

[135]  S. Attar,et al.  Vitamin d deficiency in patients with systemic lupus erythematosus. , 2013, Oman medical journal.

[136]  И. Ю. Малышев,et al.  ОСОБЕННОСТИ ФАГОЦИТАРНОЙ И МИГРАЦИОННОЙ АКТИВНОСТИ АЛЬВЕОЛЯРНЫХ МАКРОФАГОВ М1 И М2 ФЕНОТИПОВ , 2011 .

[137]  池田 詩子.  1α,25-dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells , 2011 .

[138]  Roberto A. Maldonado,et al.  How tolerogenic dendritic cells induce regulatory T cells. , 2010, Advances in immunology.

[139]  P. Wilson,et al.  Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. , 2008, The American journal of clinical nutrition.

[140]  J. Cerhan,et al.  Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. , 2004, Arthritis and rheumatism.

[141]  M. Uskoković,et al.  A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. , 2002, Diabetes.

[142]  C. Patterson,et al.  Infections and vaccinations as risk factors for childhood Type I (insulin-dependent) diabetes mellitus: a multicentre case-control investigation , 2000, Diabetologia.

[143]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[144]  Dong-Youn Lee,et al.  Vitamin D receptor polymorphism is associated with psoriasis. , 1999, The Journal of investigative dermatology.

[145]  H. DeLuca,et al.  1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. , 1998, The Journal of nutrition.

[146]  H. Mcdevitt,et al.  Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. , 1995, Immunology today.

[147]  H. Erlich,et al.  MHC class-II molecules and autoimmunity. , 1991, Annual review of immunology.

[148]  Y. Higashimoto,et al.  O R I G I N a L I N V E S T I G a T I O N Open Access , 2022 .